RESEARCH
Circulating Tumor DNA Predicts Recurrence Risk in Stage III Colorectal CancerA systematic review and meta-analysis found that circulating tumor DNA (ctDNA) testing can help predict which stage III colorectal cancer patients are at higher risk of recurrence after surgery. (Clinical Colorectal Cancer)